Upon the next follow-up, semaglutide was re-introduced for the next 33 months, which led to a 7 kg weight reduction during the first two years of treatment (113 kg, BMI 52.65 kg/m 2 ), followed by a slight weight regain during the third year
GLP-1 receptor agonists, a class of medications used to treat Type 2 diabetes and obesity, are known to slow gastric emptying
10.1177/1479164116653240 Diabetes Vasc
Kamel suggests that, while more evidence is growing regarding the use of cannabis (largely due to legalization), I personally do not think it will be reversed, as many other substances with established risks still remain accessible. The purpose of this study is to help physicians risk-stratify patients and provide the best support for them, he said
If semaglutide is not working, tirzepatide may be more effective due to its dual receptor mechanism
Contact your weight loss doctor if you have issues with the effectiveness of your GLP-1 medication while taking antibiotics, and your general practitioner if your symptoms are getting worse or you are not improving